Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
English (EN)
2022
Americas
Clear all
Type of publications
NITAG documentation
(24)
Topics
Regions
Americas
(24)
Africa
(3)
Europe
(14)
Western Pacific
(10)
Countries
Canada
(13)
United States of America
(11)
Diseases
COVID-19
(24)
Cholera
(3)
Ebola
(1)
Hepatitis B
(2)
Human papillomavirus (HPV)
(3)
Influenza
(3)
Measles
(1)
Mpox // Monkeypox
(3)
Mumps
(1)
Pneumococcal disease
(3)
Rabies
(1)
Rubella
(1)
Publication date
2022
(24)
2024
(1)
2023
(6)
2021
(50)
2020
(51)
Target population
Adolescents
(1)
Children
(1)
Pregnant women
(1)
Available to download in languages
English (EN)
(24)
Spanish (ES)
(7)
24 results found
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2022
∙
NACI
Updated guidance on COVID-19 vaccine booster doses in Canada
2022
∙
NACI
Recommendations on the use of bivalent Omicroncontaining mRNA COVID-19 vaccines
2022
∙
Public Health Agency of Canada
Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding
2022
∙
ACIP
ACIP Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines
2022
∙
ACIP
ACIP Update to the Evidence to Recommendations for a Pfizer-BioNTech COVID-19 Booster in Children Ages 5-11 Years
2022
CDC Clinical Considerations for Second COVID-19 Vaccine Booster Dose
2022
∙
Sara Oliver, ACIP
Evidence to recommendation Framework: mRNA COVID-19 vaccine in young children
2022
∙
ACIP
GRADE for Moderna COVID-19 Vaccine for Children Aged 6 Months–5 Years
2022
∙
ACIP
GRADE for Pfizer-BioNTech COVID-19 Vaccine for Children Aged 6 Months–4 Years
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register